A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib
Clinical trial NCT03804515 · TERMINATED
Trial details
- NCT number
- NCT03804515
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2020-02-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.